R3 Stem Cell (R3) is an innovative regenerative medicine “add-on” model to an existing medical practice that desires to offer the most cutting edge stem cell procedures available to generate new revenue streams. Stem cell therapy is now mainstream, and R3 offers a turnkey value proposition to turn a medical practice into a Regenerative Center of Excellence.
Currently, stem cell procedures represent a fee-for-service model, which a lot of medical practices are not used to incorporating into their practice. This along with marketing to this very specific target market is where R3’s expertise allows us to institute and manage the whole service offering for you. R3 represents a disruptive innovation in how practices add a state of the art, high profit margin, service offering. R3 will help you differentiate yourself from your competitors and become a leader in stem cell procedures.
Patients who have degenerative arthritis or disc disease, tendonitis or ligament injuries, non-healing fractures or sports injuries would prefer to heal without surgery. Early studies have shown the benefits of regenerative stem cell procedures for helping patients avoid or delay the need for surgery, while getting athletes back into high-level sports faster than ever seen previously.
The target market for regenerative medicine is quite large and rapidly growing. R3 understands this, and works selectively with medical practices in the following specialties:
By offering a turnkey program, your practice can focus on patient care while the standard operating procedures of R3 elevate the practice’s reputation in the community.
Amniotic and Umbilical Cord Stem Cell Treatments
The most revolutionary regenerative medicine treatments now being offered include amniotic and umbilical stem cell treatments. These are FDA regulated and contain growth factors, hyaluronic acid, cytokines and stem cells.